Disitamab vedotin HER2 | Read Reviews & Product Use Citations

Disitamab Vedotin (RC-48 ,RC 480-ADC) is an antibody-drug conjugate(ADC) composed of anti-[ERBB2 (epidermal growth factor receptor 2, receptor tyrosine-protein kinase erbB-2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)] humanized monoclonal antibody, conjugated to monomethylauristatin E (MMAE), via a cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker. Disitamab Vedotin has the potential for use in solid tumors mainly in advanced breast cancer.

CAS No. 2136633-23-1

Click to purchase products related to Disitamab vedotin

1 Citation

17 Nobel Prize winners have used Selleck products

Shimon Sakaguchi

Nature Communications 2025,16, Article number:1325

David Baker

Dev Cell 2023, 58(20):2163-2180.e9.

David Julius

Cell 2017, 185-198.e16

Michael Houghton

Cell Chem Biol, 2020, 27(7):780-792.e5

Charles M. Rice

Cell 2018, 172(3):423-438.e25

Quality Control

Batch: D404901 Purity: 99.17% Protein concentration: 3.3mg/ml Endotoxin Level: ＜1EU/mg

Cited in Nature Medicine for its top-tier quality
COA
SDS
Datasheet

99.17

Specificity

Name	Citation	HER2	Others
Canertinib (CI-1033)	48	+++	EGFR
CP-724714	109	+++
Sapitinib (AZD8931)	50	++++	ErbB3,EGFR
CUDC-101	23	++	EGFR,HDAC,HDAC1
Mubritinib (TAK 165)	40	++++
AEE788 (NVP-AEE788)	13	++++	EGFR,c-Abl,FLT1
AC480 (BMS-599626)	10	++	HER1,HER4
TAK-285	4	++	EGFR/HER1,HER4,MEK1
Tyrphostin AG 879	3	+	Trk
Tuxobertinib (BDTX-189)	2	++++	EGFR,RIPK2,BLK
Epertinib hydrochloride	0	++++	EGFR,HER4
TAS0728	1	+++
Tyrphostin AG-528	0	+	EGFR
SU5204	1	+	VEGFR-2
Pyrotinib dimaleate	4	+	EGFR
Poziotinib (NOV120101, HM781-36B)	35	++++	HER1,HER4
HER2-Inhibitor-1	1	✔
Zongertinib (BI 1810631)	1	✔	EGFR-Ex20ins
Nordihydroguaiaretic acid (NDGA)	1	✔	p300,IGF-1R,lipoxygenase
EGCG ((-)-Epigallocatechin Gallate)	42	✔	FASN,EGFR,DNMT

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description	Disitamab Vedotin (RC-48 ,RC 480-ADC) is an antibody-drug conjugate(ADC) composed of anti-[ERBB2 (epidermal growth factor receptor 2, receptor tyrosine-protein kinase erbB-2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)] humanized monoclonal antibody, conjugated to monomethylauristatin E (MMAE), via a cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker. Disitamab Vedotin has the potential for use in solid tumors mainly in advanced breast cancer.
References	[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090390/

Description

Disitamab Vedotin (RC-48 ,RC 480-ADC) is an antibody-drug conjugate(ADC) composed of anti-[ERBB2 (epidermal growth factor receptor 2, receptor tyrosine-protein kinase erbB-2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)] humanized monoclonal antibody, conjugated to monomethylauristatin E (MMAE), via a cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker. Disitamab Vedotin has the potential for use in solid tumors mainly in advanced breast cancer.

References

[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090390/

Product Details

CAS No.	2136633-23-1
DAR	3.8
ADC antiody	Disitamab
ADC cytotoxin	MMAE
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.